Renaissance Technologies - CHELSEA THERAPEUTICS INTL LT ownership

CHELSEA THERAPEUTICS INTL LT's ticker is CHTP and the CUSIP is 163428105. A total of 79 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q4 2013. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CHELSEA THERAPEUTICS INTL LT
ValueSharesWeighting
Q1 2014$184,000
-94.2%
33,306
-95.4%
0.00%
-100.0%
Q4 2013$3,178,000
+370.8%
716,494
+217.5%
0.01%
+300.0%
Q3 2013$675,000
+2712.5%
225,695
+2071.4%
0.00%
Q2 2013$24,00010,3940.00%
Other shareholders
CHELSEA THERAPEUTICS INTL LT shareholders Q4 2013
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 100,000$13,400,0000.04%
WHITEBOX ADVISORS LLC 2,777,092$555,0000.02%
CSS LLC/IL 45,000$290,0000.01%
Polar Asset Management Partners Inc. 750,000$60,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 396,300$2,584,0000.00%
NORTHERN TRUST CORP 648,574$4,229,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 56,400$368,0000.00%
AMERIPRISE FINANCIAL INC 30$00.00%
DEUTSCHE BANK AG\ 23$00.00%
CITIGROUP INC 74$00.00%
View complete list of CHELSEA THERAPEUTICS INTL LT shareholders